AB141980
Zoledronic acid, FPP synthase inhibitor
Be the first to review this product! Submit a review
|
(2 Publications)
MW 272.09 Da, Purity >98%. Highly potent bisphosphonate. FPP synthase inhibitor. Inhibits osteoclastogenesis (IC50 = 15 nM). Inhibits ASM and FDPS. Activates PKC. Inhibits osteoclastic bone resorption, shows antihypocalcemic and antiangiogenic effects in vivo. .
1 Images
- Chemical Structure
Lab
Chemical Structure - Zoledronic acid, FPP synthase inhibitor (AB141980)
2D chemical structure image of ab141980, Zoledronic acid, FPP synthase inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cancer immunology, immunotherapy : CII 70:1213-1226 PubMed33119798
2020
B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
Applications
Unspecified application
Species
Unspecified reactive species
Huimin Lu,Yanchao Ma,Mingyuan Wang,Jin Shen,Hongya Wu,Juntao Li,Nan Gao,Yanzheng Gu,Xueguang Zhang,Guangbo Zhang,Tongguo Shi,Weichang Chen
Oncoimmunology 9:1748991 PubMed32363121
2020
B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.
Applications
Unspecified application
Species
Unspecified reactive species
Huimin Lu,Tongguo Shi,Mingyuan Wang,Xiaomi Li,Yanzheng Gu,Xueguang Zhang,Guangbo Zhang,Weichang Chen
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com